BioBasel News
Swiss National Science Foundation-grant to boost immune system research in Basel Friday, July 03, 2009 BASEL, Switzerland - The Swiss National Science Foundation (SNF) has recently awarded a 2 Million CHF research grant to a team of scientists from the Biozentrum and the Department of Biomedicine in Ba... |
Phase III study showed Lucentis improved vision in patients with branch retinal vein occlusion Friday, July 03, 2009 SOUTH SAN FRANCISCO, Calif. - Genentech, Inc. announced today that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change... |
Swine flu vaccine made in Europe Friday, July 03, 2009 The first doses of an H1N1 swine flu vaccine have been produced in Europe - but it will be around two months before any is distributed. The doses were produced by Novartis at a plant in Marburg, Germa... |
Roche NimbleGen CNV arrays selected for landmark Korean copy number variation study Friday, July 03, 2009 MADISON, WI, USA - Roche NimbleGen has entered into a partnership with the Korea Centers for Disease Control and Prevention (KCDC) and Macrogen, Inc. to conduct an 8-month intensive Copy Number Variat... |
Clariant successfully completes the placement of a CHF 300 million Convertible Bonds issue Friday, July 03, 2009 MUTTENZ, Switzerland - Clariant is pleased to announce the successful placement of a CHF 300 million senior unsecured Convertible Bond offering due 2014 (the Convertible Bonds). The final terms have n... |
Fukuda Denshi announces loss on valuation of investment securities Friday, July 03, 2009 Fukuda Denshi Co., Ltd. announced that a loss on valuation of investment securities was recorded in its financial results for the first quarter of the fiscal year ended March 2010 as follows. |
Roche Pharma Switzerland receives the sixth Walter Siegenthaler Medien und Medizin Verlag (MMV) Award for Avastin Friday, July 03, 2009 BASEL, Switzerland - Roche Pharma Switzerland tonight receives the sixth Walter Siegenthaler MMV Award in Davos. The Award is being given for Avastin, a monoclonal antibody that inhibits angiogenesis,... |
BD Biosciences launches new portfolio of surfaces for cell-based drug discovery screening and basic cell culture research Friday, July 03, 2009 BILLERICA, MA - BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the launch of its new line of BD PureCoat cell culture surfaces designed to help life science researche... |
Japan finds first case of H1N1 resistant to Tamiflu Friday, July 03, 2009 TOKYO - Japan has confirmed its first case of a genetic mutation of the new H1N1 flu virus that shows resistance to Tamiflu, the main antiviral flu drug, a health ministry official said on Thursday. |
Pall Life Sciences receives Supplier of the Year Award from VWR Europe Friday, July 03, 2009 EAST HILLS, N.Y. - Pall Life Sciences, a global leader in filtration, separation and purification, received the 2008 Supplier of the Year Award from the European segment of VWR for its commitment to ... |
Thomson Reuters publishes three Pharma Matters reports covering the first quarter of 2009 Friday, July 03, 2009 PHILADELPHIA and LONDON - The Healthcare & Science business of Thomson Reuters today announced the availability of three Pharma Matters reports covering the time period January - March 2009. The quart... |
Life Technologies sets Q2 2009 earnings release date for Tuesday, July 28, 2009 Friday, July 03, 2009 CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its second quarter 2009 financial results on Tuesday, July 28, 2009, after market close. The company will... |
An update regarding follow-on biologics Friday, July 03, 2009 The debate over whether or not lower cost, "generic" versions of biologics and biotechnology drugs ought to be brought to market has been a very long and contentious one. However, rising healthcare co... |
Memo to biotech CEOs: Keep hands off the cash Friday, July 03, 2009 LONDON - U.K. shareholders have been incensed by big pay packages for executives during the current recession, decrying them as rewards for failure as company earnings nose-dive. The latest sector to ... |
Cellular Dynamics International and Roche expand existing cardiotoxicity screening agreement Friday, July 03, 2009 MADISON, Wis. - Cellular Dynamics International (CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause car... |
Genzyme: The next big biotech machine Friday, July 03, 2009 Rarely do I even acknowledge biotech equities due to the inherent risk and uncertainty in the industry. But as of late, one biotech firm has garnered my attention, due to extremely high margin of saf... |
Clariant launches approximately CHF 225 million Senior Unsecured Convertible Bonds due 2014 Friday, July 03, 2009 MUTTENZ, Switzerland - Clariant (SIX Swiss Exchange; CH0012142631) announces today that it intends to launch an offering (the Offering) of approximately CHF 225 million of senior unsecured convertible... |
Sucampo reports top-line results of Phase 2 clinical trial of Cobiprostone for prevention of NSAID-induced gastrointestinal injuries Friday, July 03, 2009 BETHESDA, Md. 2- Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today reported top-line results from its phase 2 clinical trial of orally admi... |
Bayer files patent infringement lawsuit against Teva Friday, July 03, 2009 LEVERKUSEN,Germany Bayer Schering Pharma AG, Germany and Bayer HealthCare Pharmaceuticals Inc. together with Schering Corporation have filed a patent infringement lawsuit in the U.S. Federal Court in... |
Novozymes added to core list of world's top 20 sustainable business stocks Friday, July 03, 2009 Novozymes is once again on the list of the worlds top 20 leading companies within sustainability and finance compiled by SustainableBusiness.com. |
